Dimensional Fund Advisors LP Aptevo Therapeutics Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$1.74 - $2.54 $161 - $236
-93 Reduced 0.73%
12,612 $25,000
Q4 2022

Feb 09, 2023
BUY
$2.0 - $138.16 $25,410 - $1.76 Million
12,705 New
12,705 $29,000
Q1 2021

May 14, 2021
SELL
$27.86 - $40.59 $153,285 - $223,326
-5,502 Closed
0 $0
Q4 2020

Feb 25, 2021
BUY
$6.21 - $48.36 $34,167 - $266,076
5,502 New
5,502 $202,000

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $22.4M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email